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Abstract
Adenovirus type 5 (Ad5) is a non-enveloped DNA virus frequently used as a gene transfer vector. Efficient Ad5 cell entry
depends on the availability of its primary receptor, coxsackie and adenovirus receptor, which is responsible for attachment,
and integrins, secondary receptors responsible for adenovirus internalization via clathrin-mediated endocytosis. However,
efficacious adenovirus-mediated transgene expression also depends on successful trafficking of Ad5 particles to the nucleus
of the target cell. It has been shown that changes occurring in tumor cells during development of resistance to anticancer
drugs can be beneficial for adenovirus mediated transgene expression. In this study, using an in vitro model consisting of a
parental cell line, human laryngeal carcinoma HEp2 cells, and a cisplatin-resistant clone CK2, we investigated the cause of
increased Ad5-mediated transgene expression in CK2 as compared to HEp2 cells. We show that the primary cause of
increased Ad5-mediated transgene expression in CK2 cells is not modulation of receptors on the cell surface or change in
Ad5wt attachment and/or internalization, but is rather the consequence of decreased RhoB expression. We propose that
RhoB plays an important role in Ad5 post-internalization events and more particularly in Ad5 intracellular trafficking. To the
best of our knowledge, this is the first study showing changed Ad5 trafficking pattern between cells expressing different
amount of RhoB, indicating the role of RhoB in Ad5 intracellular trafficking.
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Introduction
Adenovirus-based vectors are leading vectors used in gene
therapy clinical trials today. Human adenovirus type 5 (Ad5) is a
dsDNA virus with an icosahedral, non-enveloped capsid composed
of 240 hexon protein trimers and 12 pentons, each of which
comprising a pentameric penton base and a trimeric fiber protein
that protrudes from the apex of the penton base [1]. Ad5 infection
begins with high-affinity binding of the fiber protein to the
coxsackie-adenovirus receptor (CAR) on the cell surface [2].
Interaction between RGD motifs of the penton base and cell-
surface integrins (avb3, avb5, avb1, a5b1 and a3b1) then triggers
internalization of the viral particle [3,4,5,6].
In order to enter the host cell, adenoviruses use existing cell
entry pathways. Ad5 internalization is mostly mediated by
dynamin- and clathrin-dependent receptor-mediated endocytosis
[7], although there is evidence that some capsid-modified Ad5-
based vectors can enter the cell by using lipid raft- and caveolae-
mediated endocytosis [8]. After being internalized, Ad5 continues
part of its intracellular journey in the endosome. It is widely
accepted that escape of Ad5 from the endosome is induced by
endosomal acidification. Lowering pH in the endosome allows
dismantling of the Ad5 capsid and release of the membrane-lytic
internal protein VI, which then triggers penetration of the
endosome. It has also been shown that integrin avb5 plays an
important role in the release of Ad5 from the endosome [9,10,11].
Once in the cytoplasm, adenovirus encounters complex networks
of organelles and proteins, which severely impair diffusive
mobility. Therefore, intracellular trafficking of Ad5 cannot rely
on simple diffusion, but rather involves active transport. After
being liberated from the endosome, adenovirus binds directly to
the microtubule minus end-directed motor dynein and is
transported all the way to the nucleus [12]. The process of
adenovirus endocytosis is regulated by lipid kinases and actin-
modulating small GTPases, and has been shown to require
assembly of the actin cytoskeleton, an event initiated by activation
of PI3K and, subsequently, Rac and Cdc42, members of the Rho
GTPase family [13].
Rho GTPases are members of the Ras superfamily of
monomeric GTP-binding proteins that have an important role
in regulating the actin cytoskeleton and membrane trafficking.
While RhoA, Rac and Cdc42 localize to the plasma membrane
and are involved in receptor internalization, RhoB is found both at
the plasma membrane and endosomes and has been suggested to
regulate endosomal traffic [14]. RhoB is involved in traffic to the
cell surface, nucleus, or lysosome, and/or activation of a number
of signaling molecules, such as RTKs, Akt and Src [15,16,17]. It
has recently been reported that activated RhoB promotes the
polymerization of an actin coat around endosomes and association
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of these vesicles to subcortical actin cables, thus effectively
inhibiting further endosomal transport [18]. It has been also
proposed that RhoB plays a key role in the recycling/degradation
sorting decision in CXCR2 receptor trafficking [19]. RhoB was
found to play a role in entry of Ebola virus and vesicular stomatitis
virus, two enveloped viruses that use different receptors but
converge on a common Rho-mediated pathway, suggesting that
this may be a route of entry utilized by many different viruses [20].
From the literature it is known that interfering with actin can
impede adenovirus-mediated transduction [21,22]; at present,
however, no data are available concerning the role of RhoB in
adenovirus entry.
Second only to heart disease, cancer is a major medical cause of
death in the human population. Standard cancer treatment
includes surgery, chemotherapy, radiation therapy, and immuno-
therapy. A very important drawback of chemotherapy, which is
often used as a treatment of choice, is the development of
chemoresistance. Cancer cells develop resistance to the applied
anti-cancer drug through various mechanisms, which in many
cases allow them to escape the toxic effect of various anti-cancer
drugs, in spite of their different chemical structures and modes of
action. Gene therapy, though originally designed as a treatment
for monogenetic illness, has emerged as an alternative strategy in
cancer treatment. Adenovirus-based vectors are particularly
promising, as they can be successfully combined with other
therapies. In the literature a growing number of studies report
encouraging results obtained by combined use of adenoviruses,
whether replication deficient or conditionally replicating, with
chemotherapy [23,24,25]. An attractive feature of the combined
approach is that some drug treatments enhance adenovirus
infection of cancer cells by changing expression of receptors
involved in adenovirus entry, such as CAR [26]. Furthermore, in
cell clones resistant to multiple anti-cancer drugs, certain changes
that increase Ad5-mediated transgene expression have been
characterized, including up-regulation of CAR and integrin
avb3 in a human laryngeal carcinoma cells resistant to cisplatin
CA3ST [27] or increased activity of a Rous sarcoma virus
promoter driving Ad5-mediated transgene expression in human
laryngeal carcinoma cells resistant to vincristine, [28].
In our laboratory we have developed a cisplatin-resistant cell
line, CK2, by chronic exposure of a human laryngeal carcinoma
cell line, HEp2, to cisplatin [29]. CK2 cells differ from the parental
cell line both in morphology and in the formation of cell–cell
adherens junctions in the resistant clone [30]. Moreover, in CK2
cells the down-regulation of RhoB has recently been reported to be
one of the causes of drug resistance [31]. We have observed that
Ad5-mediated transgene expression is higher in the cisplatin-
resistant CK2 cell line than in parental HEp2 cells. In the present
study we have investigated the molecular mechanisms responsible
for this effect. We show here that the observed difference in Ad5-
mediated transgene expression is not simply the consequence of
differential expression of receptors involved in adenovirus entry,
but is principally due to altered constitutive RhoB expression. We
show that silencing RhoB expression, in both parental HEp2 and
cisplatin-resistant CK2 cell lines, dramatically increases Ad5-
mediated transgene expression regardless of receptor usage,
indicating that RhoB might have a general role in the post-




Human laryngeal carcinoma (HEp2) cells were obtained from a
cell culture bank (GIBCO/BRL Invitrogen, Germany) and grown
in Dulbecco’s modified Eagle’s medium (DMEM) supplemented
with 10% bovine serum (Invitrogen, Germany) at 37uC with 5%
CO2 in a humidified atmosphere. The development of HEp2-
derived CK2 cells that are resistant to cisplatin (referred to in the
text as cisplatin-resistant cells) has been previously described
[29,32]. Before using the CK2 cells in this study, the cells were
tested for cisplatin resistance. As reported previously [32], CK2
cells were approximately 1.5- to 2-fold more resistant to cisplatin
than HEp2.
Adenovirus Vectors
All replication-deficient adenovirus vectors used in this study are
based on adenovirus type 5 and have been previously described as
listed in Table 1. All vectors were amplified in human embryonic
kidney (HEK-293) cells, banded in CsCl gradients and stored at
280uC in aliquots. The virus particle concentration was measured
by optical density according to the protocol described by
Mittereder et al. [33]. All viruses contain the reporter gene lacZ
under the control of the RSV promoter. Adenovirus blue forming
units (b.f.u.) were determined in HEK-293 cells as previously
described by [34].
Adenovirus Labeling
After purification by banding in CsCl and dialysis against PBS
buffer, adenovirus particles were incubated with a 20-fold excess of
chemically reactive Alexa488-TFP (Molecular Probes, USA) for 2
hours at room temperature in PBS buffer, pH 7.2. The reaction
was stopped by incubation for 5 minutes with a 5-fold excess of
lysine over Alexa488-TFP. The labeled vector particles were then
purified from excess dye by dialysis using Slide-A-Lyzer 10 K
dialysis cassettes (Pierce). The transduction efficiency of the
modified vector was analyzed by transduction assay in HEK-293
cells. Alexa488-TFP labeling did not alter transduction efficacy of
Ad5wt in these cells.
Determination of Cell Surface Receptor Expression by
Flow Cytometry
Flow cytometry was used to analyze expression of integrin
heterodimers avb3, avb5 and a3b1, as well as integrin subunits
av, a5 and b1, and CAR in HEp2 and CK2 cell lines. Briefly,
adherent cells were grown in tissue culture dishes (until 80%
confluency), detached with Versene (Invitrogen, USA) and washed
twice with PBS. Subsequently cells were incubated on ice with the
Table 1. Replication defective Ad5s used in a study.
Adenovirus Fiber modification Reference
HI loop shaft
Ad5wt none none [11]
Ad5RGD4C CDCRGDCFC insertion none [11]
Ad5D639 none 8 instead of
22 repeats
[34]
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following antibodies: FITC-conjugated anti-human avb3 integrin
MAb (23C6, Pharmingen), anti-human avb5 integrin MAb
(MAB1961, Chemicon), anti-human a3b1 integrin MAb
(MAB1992, Chemicon), anti-human b1 integrin MAb (JB1A,
Chemicon), anti-human a5 integrin MAb (MAB1956Z, Chemi-
con), anti-human av integrin MAb (272-17E6, Merck) and anti-
human CAR MAb (RmcB, Upstate Cell Signaling Solutions). The
binding of unlabeled primary antibodies was revealed by using PE-
conjugated anti-mouse Ig antibody (DAKO, USA) as secondary
reagent. Isotype control samples were incubated with FITC-
conjugated mouse IgG1, mouse IgG1 (Sigma, Germany) or mouse
IgG3 (Invitrogen), depending on the isotype of the MAb requiring
the control, followed by PE-conjugated anti-mouse Ig antibody
(DAKO, USA) where needed.
Measurement of Ad5-mediated Transgene Expression
Ad5-mediated transgene expression was measured as described
previously [11]. Briefly, 104 cells per well were plated in 96-well
plates. Twenty-four hours later, cells were transduced in a final
volume of 50 ml (in triplicate) with serial two-fold dilutions of all
adenoviruses normalized for physical particle number. After 1
hour, viruses were removed and fresh medium was added.
Twenty-four hours after infection, cells were fixed with 0.5%
glutaraldehyde and stained for b-gal expression using X-gal as a
substrate. The number of stained cells was determined by light
microscopy. Cells were counted in each well in which the number
of blue cells was between 50 and 150. The results are expressed as
the number of b-galactosidase-positive cells normalized to the
number of physical particles used for infection.
Adenovirus Attachment and Internalization Measured by
Real Time PCR
Adherent HEp2 and CK2 cells were grown in 35-mm tissue
culture dishes (until 80% confluency). Purified Ad5wt, 1000
physical particles per cell (pp/cell), was added to cells and
incubated for 40 minutes on ice. To measure attachment,
unbound viruses were removed by washing the cells twice with
cold trypsin and twice with cold PBS. Cells were then harvested
with a cell scraper and pelleted by centrifugation. To measure
internalization, unbound viruses were removed and warm growth
medium was added. After incubation at 37uC for 40 minutes, cells
were washed twice with cold trypsin, trypsinized for 7 minutes at
37uC and, after addition of PBS, immediately pelleted by
centrifugation. Total DNA (cellular plus viral) was extracted from
cell pellets with commercially available materials (DNeasy Kit,
Qiagen) and used to quantify viral DNA.
To measure the extent of viral attachment or internalization,
viral DNA was quantified by real-time PCR using a target
sequence within the gene encoding hexon and by using the
QuantiTect SYBR Green PCR Kit (QIAGEN) and Bio-Rad
CFX96 Real Time PCR Detection System (Biorad). The primers
used were Hexon-1 (59- CGCGGTGCGGCTGGTG -39) and
Hexon-2 (59- TGGCGCATCCCATTCTCC -39). The DNA
content per PCR reaction was normalized by a second real-time
PCR assay targeting the GAPDH gene using GAPDH1 (59-AGA
ACA TCA TCC CTG CCT CTA CTG-39) and GAPDH2 (59-
TGT CGC TGT TGA AGT CAG AGG AGA-39) primers.
siRNA Experiments
To silence RhoB, we used Silencer Select Predesigned siRNA
(catalog No. 4390817, locus ID 388, Ambion, Austin, TX). As a
negative control we used non-targeting control siRNA Silencer
Select Predesigned siRNA (Negative control #1, catalog
No. 4390844, Ambion). Cells were transfected at a confluency of
30–50% in six-well dishes, using Lipofectamine RNAiMAX
reagent (Invitrogen) according to the manufacturer’s protocol for
forward transfection. In forward transfections, cells are plated in
the wells, and the transfection mix is prepared and added the next
day. Twenty-four hours after transfection cells were replated for
subsequent experiments, evaluation of Ad5-mediated transgene
expression or Western blot. Silencing of RhoB expression was
verified by Western blot on whole cell lysates 48 hours after
transfection using polyclonal antibody against RhoB (Santa Cruz
Biotechnology, Santa Cruz, CA). At the same time cells were
infected with Ad5 vectors for measurement of Ad5-mediated
transgene expression.
Confocal Microscopy Studies
HEp2 and CK2 cells (26104 per coverslip) were seeded in 24-
well plates. The next day labeled adenoviruses were added to cells
(46104 pp/cell) and incubated on ice for 60 minutes. For analysis
of binding, unbound viruses were removed and cells were fixed.
For analysis of internalization, unbound viruses were removed and
replaced with warm medium; cells were then incubated at 37uC
for 30 minutes prior to fixation. In both cases cells were fixed with
2% paraformaldehyde in PBS for 15 minutes at room tempera-
ture. Nuclei were labeled with 5 mM DRAQ5H for 10 minutes at
37uC. Coverslips were slide mounted by using Fluoromount
(SouthernBiotech, USA). Confocal laser scanning microscopy
(CLSM) analyses were performed using a Zeiss Axiovert 200M
microscope coupled with a Zeiss LSM 510 scanning device (Carl
Zeiss Co. Ltd., Iena, Germany). Observations were made with a
x63 objective.
Statistical Analysis
Each experiment was repeated at least three times. The data
were analyzed by the unpaired Student’s t-test and expressed as
means 6 standard deviation. Data were considered statistically
significant at a p-value of ,0.05.
Results
Characterization of Receptors Involved in Ad5
Transduction in Parental HEp2 and cisplatin-resistant CK2
Cells
Drug-resistant cancer cells may exhibit increased Ad5-mediated
transgene expression due to altered expression of receptors
involved in Ad5 infection [26,27]. CK2 cells used in this study
were developed in our laboratory by chronic exposure of HEp2
cells to cisplatin [29] and in our hands proved to remain
approximately 1.5- to 2-fold more resistant to cisplatin than
HEp2, as previously reported [32]. In order to find out whether
development of cisplatin resistance in the CK2 cell line was
accompanied by changes in the repertoire of the cell surface
receptors involved in Ad5 infection, we analyzed their expression
in HEp2 and CK2 cells by flow cytometry. Data obtained by flow
cytometry are presented as histograms (Figure 1A), with corre-
sponding MFI values expressed as the ratio of the MFI for CK2
and HEp2 cells (Figure 1B). No significant difference in av integrin
subunit expression was found between HEp2 and CK2 cells,
although there was a slight increase in expression of CAR and b1
integrin subunit and an approximately 2-fold increase in
expression of a3b1 integrin heterodimer and a5 integrin subunit.
Like the HEp2 cell line [27], CK2 cells do not express avb3
integrin (Figure 1A). The only molecule that was found to be
down-regulated in CK2 as compared with HEp2 cells was the
integrin heterodimer avb5, which is very important not only for
RhoB Role in Adenovirus Intracellular Trafficking
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Ad5 internalization but also for endosome release and has indeed
been shown to be a limiting factor for successful Ad5 internali-
zation [10,11].
Ad5-mediated Transgene Expression in Cisplatin-
resistant CK2 Cells is Higher than in Parental HEp2 Cell
Line
Next, we investigated whether there was a difference in Ad5-
mediated transgene expression between cisplatin-resistant CK2
cells and their parental HEp2 cell line. We transduced CK2 cells
with four different Ad5 vectors, Ad5wt, Ad5RGD4C, Ad5D639
and Ad5D639RGD4C, and measured the number of cells
expressing the reporter gene product, b-galactosidase. The
RGD4C insertion in the HI-loop of fiber protein allows increased
adenovirus binding and internalization through av-integrins [35],
which we have confirmed in HEp2 cells [11]. Shortening the Ad5
fiber shaft by introduction of the D639 mutation renders
transduction by Ad5D639 and Ad5D639RGD4C vectors inde-
pendent of CAR [34]. Figure 2A shows that regardless of the
modification, all Ad5 vectors tested transduced CK2 cells more
efficiently than HEp2 cells, with a fold increase ranging from 5 for
Ad5wt and Ad5RGD4C to 8–10 for Ad5D639 and
Ad5D639RGD4C, respectively (Figure 2B). Since the RGD4C-
modified viruses Ad5RGD4C and Ad5D639RGD4C did not
present significant improvement in transgene expression in
comparison with their unmodified counterparts, Ad5wt and
Ad5D639, we can conclude that increased Ad5-mediated trans-
gene expression in CK2 cells is not the consequence of increased
expression of RGD-binding integrins avb1, avb3, avb5, and
a5b1.
The CK2 cells express 50% more CAR on their cell surface
than HEp2 cells. Due to their short and rigid fiber, Ad5D639 and
Ad5D639RGD4C enter cells independently of CAR expression
[11,34]. If the increased Ad5-mediated transgene expression in
CK2 cells, as compared with cells, is primarily related to increased
CAR expression, we would expect the ratio of transgene
expression in CK2 and HEp2 cells to be higher for CAR-
dependent (Ad5wt and Ad5RGD4C) than CAR-independent
(Ad5D639 and Ad5D639RGD4C) vectors. We observed, however,
that transgene expression was 5.3- and 7.7-fold higher in CK2 cells
for Ad5wt and Ad5D639, respectively, and 5- and 10-fold higher
for Ad5RGD4C and Ad5D639RGD4C, respectively. Thus, the
magnitude of the increase in transgene expression in CK2 cells
was comparable for CAR-dependent and CAR-independent
vectors, suggesting that factors other than CAR expression
improved Ad5-mediated transgene expression in CK2 cells.
Our group has previously shown that drug-resistance may be
accompanied with alteration in promoter activity of the Rous
sarcoma virus (RSV) long terminal repeat (LTR), thereby affecting
Ad5-mediated transgene expression when transgenes are placed
under control of the RSV LTR [28]. To determine whether
increased transgene expression might be related to use of the RSV
Figure 1. Cell surface levels of CAR, integrin heterodimers avb3, avb5 and a3b1, integrin subunits a5, av and b1 on HEp2 and CK2
cells. Cells were detached by Versene and incubated with murine monoclonal antibodies or isotype-matched antibody as a negative control. After
incubation with the secondary reagent (i.e. PE-conjugated anti-mouse antibody), labeled cells were analyzed by flow cytometry. (A). Representative
histograms and (B) mean fluorescence intensities relative to HEp2 cells obtained in one of three independent experiments that provided similar
results are shown.
doi:10.1371/journal.pone.0086698.g001
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LTR, we measured transgene expression in HEp2 and CK2 cells
after transduction with Ad5CMVbgal, which differs from Ad5wt
only in that the intermediate/early promoter of CMV drives
expression of the lacZ transgene. We observed that CMV-driven
transgene expression was increased to a similar extent (5-fold) in
CK2 cells (data not shown), and therefore conclude that increased
transgene expression in CK2 cells is unlikely to be caused by
change in promoter activity.
Ad5wt Shows Slightly Higher Attachment and
Internalization in the CK2 Cell Line
As shown in previous sections of this study, certain cell surface
molecules involved in adenovirus infection are differentially
expressed in the cisplatin-resistant cell line CK2, but the modest
differences observed seemed unlikely to be the main cause of
increased Ad5-mediated transgene expression in CK2 cells. To
determine whether early steps in adenovirus infection were
nevertheless altered in the cisplatin-resistant cell line, we compared
attachment and internalization of Ad5wt in CK2 and HEp2 cells
by real-time PCR. As can be seen in Figure 3, attachment and
internalization of Ad5wt were approximately 1.4-fold and 1.8-fold
higher, respectively, in CK2 cells than in HEp2 cells (Figure 3). In
addition to real-time PCR, we measured binding and internali-
zation by semiquantitative PCR and flow cytometry. Flow
cytometry was performed as described previously [28] using a
wide range of pp/cell (750–5000). The results were similar to those
obtained by real-time PCR (data not shown). While the observed
differences in attachment and internalization were statistically
significant, we believe that they were too small to account for the
large increase in Ad5-mediated transgene expression in the CK2
cell line. This prompted us to investigate other possible
mechanisms underlying increased Ad5wt-mediated transgene
expression in CK2 cell line.
Decreasing RhoB Expression Increases Ad5-mediated
Transgene Expression
From the data previously published in our laboratory, we know
that RhoB expression is strongly down-regulated in cisplatin-
resistant CK2 cells in comparison with HEp2 cells [31]. Bearing in
mind the data from the literature showing that RhoB coordinates
endosome motility within the cell [18,36], we wished to investigate
whether RhoB expression could influence Ad5wt-mediated
transgene expression. We transfected HEp2 and CK2 cells with
RhoB-specific siRNA (30 nM and 60 nM) and 48 hours post-
transfection confirmed efficacy of RhoB silencing by Western blot
(Figure 4 A, B). Since transfection with 60 nM RhoB-specific
siRNA completely abolished RhoB expression in CK2 cells, we
decided to use 30 nM siRNA to assess the effect of decreased
RhoB in an Ad5wt transduction assay. Forty-eight hours after
transfection with control or RhoB-specific siRNA, HEp2 and CK2
cells were transduced with Ad5wt. Decreasing RhoB expression in
the HEp2 cell line brought Ad5wt-mediated transgene expression
very close to the level observed in CK2 cells (Figure 4C).
Concomitantly, the level of RhoB in HEp2 cells transfected with
RhoB-specific siRNA was close to the level of RhoB in CK2 cells
transfected with control siRNA (Figure 4C). Down-regulation of
RhoB expression increased Ad5wt-mediated transgene expression
Figure 2. Ad5-mediated transgene expression in cisplatin-resistant CK2 cells is higher than in parental HEp2 cell line. Cells were
plated in 96-well plates and, 24 hours later, infected for 1 hour at 37uC with two-fold serial dilutions of Ad5s. Twenty-four hours after infection, cells
were stained for b-galactosidase expression. A similar difference was observed over a wide range of dilutions, from 26104 to 5000 pp/cell; however,
only the transgene expression obtained with a MOI of 104 pp/cell is presented. (A). Transgene expression in HEp2 and CK2 cells after transduction
with Ad5wt, Ad5RGD4C, Ad5D639 and Ad5D639RGD4C. (B). Data shown in (A) represented as relative to HEp2 cells. The results presented are
representative of three independent experiments with similar results 6 standard deviation.
doi:10.1371/journal.pone.0086698.g002
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in both HEp2 and CK2 cell line, (4.8 and 4.6 -fold, respectively)
(Figure 4D).
To test whether the influence of RhoB silencing on transduction
by Ad5-based vectors might be a general rule, we performed the
same experiment in a human breast carcinoma cell line, MDA-
MB-435S. We obtained similar results; that is, decreasing RhoB
expression in MDA-MB-435S cell line led to a significant increase
in Ad5wt transduction efficacy (Figure S1).
Decreasing RhoB Expression has No Influence on the
Level of CAR and Integrin Expression nor on the
Efficiency of Ad5wt Attachment and Internalization
In the literature, there are a few reports connecting RhoB
expression with the expression level of integrins. It has been shown
that diminishing RhoB expression in different cell models causes
reduction in the amount of integrins available on the cell surface,
namely b1 in prostate cancer cell line [37] and b2 and b3 in
macrophages derived from RhoB2/2 mice [38]. These data led
us to examine whether silencing RhoB expression in HEp2 and
CK2 cells may have increased Ad5-mediated transduction by
influencing cell surface expression of Ad5 receptors. We analyzed
expression of CAR and integrins involved in adenovirus attach-
ment and internalization in HEp2 and CK2 cells 48 hours after
transfection with RhoB-specific and control siRNA. Silencing of
RhoB in HEp2 cells did not change expression of any of the
analyzed molecules in comparison with non-transfected cells, nor
cause additional change in expression of these receptors in the
CK2 cell line (Figure S2). Hence, increased transduction in both
HEp2 and CK2 cell line after RhoB silencing is unlikely to be due
to the modulation of CAR or integrin expression on the cell
surface.
While RhoB silencing did not change the expression of major
Ad5 receptors, we wished to test whether RhoB silencing might
nevertheless affect Ad5 attachment and internalization. After
transfected with RhoB-specific or control siRNA, we observed that
the difference in Ad5wt attachment between CK2 and HEp2 cells
was 1.3- or 1.4-fold, respectively (Figure 5A), that is, indistin-
guishable from the difference in attachment observed in non-
transfected CK2 and HEp2 cells (1.5-fold) presented in Figure 3.
Thus, transfection itself did not affect the relative efficiency of
attachment in these cell lines.
As presented in Figure 3, the difference in Ad5wt internalization
between non-transfected CK2 and HEp2 cells was approximately
1.8-fold. Transfection of these cell lines with either RhoB-specific
or control siRNA gave rise to a comparable difference in
internalization, approximately 1.5-fold for RhoB siRNA and 1.4-
fold for control siRNA (Figure 5B). Thus, while transfection itself
may have affected Ad5wt internalization and reduced the
difference between CK2 and HEp2, the reduction was unrelated
to RhoB silencing, as RhoB-specific and control siRNA produced
the same extent (a 1.5- and 1.4-fold difference, respectively)
(Figure 5B).
We conclude that the role of RhoB in differential transgene
expression is unrelated to attachment and internalization. More-
over, Ad5wt attachment and internalization in HEp2 cells were
the same after transfection with RhoB-specific or control siRNA.
The same observation held for CK2 cells, indicating that silencing
RhoB per se affected neither Ad5wt attachment nor internaliza-
tion, regardless of the cell line. The fact that silencing of RhoB in
HEp2 and CK2 cells dramatically increased Ad5wt-mediated
transgene expression, which is not the consequence of modulation
of expression of cell-surface receptors or change in Ad5wt
attachment and/or internalization, implies that RhoB may play
a role in post-internalization events, and very possibly in
intracellular trafficking.
Ad5wt Trafficking Differs in CK2 and HEp2 Cell Lines
It is widely accepted that adenovirus cell entry and translocation
to the nucleus is a rather quick event. Internalization via coated
pits occurs within 5 min, efficient liberation from endosomes
within 15 min, and 35–45 min after initiation of entry viruses are
found at nuclear pore complexes [39]. In order to study
intracellular trafficking of Ad5wt in HEp2 and CK2 cell lines,
we followed internalization of fluorescently labeled Ad5wt by
confocal microscopy. We observed Ad5wt attachment after
40 min incubation on ice, and internalization of attached Ad5wt
during 30 minutes after initiation of Ad5wt entry achieved by
transfer of cells to 37uC. Labeled Ad5wt particles can be clearly
seen attached to the surface of both HEp2 and CK2 cell lines
(Figure 6). We were unable to observe significant differences in the
number of attached particles, although it seemed that in most of
the photographs a slightly higher number of viruses were attached
to the CK2 cell surface, in agreement with attachment data
obtained by real-time PCR. The most noticeable difference
between HEp2 and CK2 cells was visible at 30 minutes after
initiation of internalization. As can be seen in Figure 6, while in
CK2 cells all viruses were located at the very border of the nucleus
at this time point, in HEp2 cells most of the viruses were still
scattered in the cytoplasm, with only a few being located close to
the nucleus. Adenovirus particles have been shown to be
transported toward the microtubule organizing center (MTOC),
which is located at a perinuclear position [40]. In the CK2 cell line
the position of Ad5wt labeled particles at 30 minutes after
initiation of internalization was consistent with localization to the
MTOC (Figure 6). The fact that fewer viruses reached the nucleus
in HEp2 cells may explain increased Ad5wt-mediated transgene
expression in CK2 cells.
Figure 3. Ad5wt shows slightly higher attachment and
internalization in cisplatin-resistant CK2 cells comparing to
parental HEp2 cell line. Cells were incubated with Ad5wt at MOI
1000 for 40 minutes on ice. To measure attachment, unbound viruses
were removed and cells were scraped off and pelleted. To measure
internalization, unbound viruses were removed and cells were
incubated at 37uC for 40 minutes, trypsinized and pelleted. Total DNA
(cellular plus viral) was extracted from cells and used as a sample for
quantification of viral DNA by real-time PCR using a region within the
hexon as the target sequence. The cell-derived DNA content per PCR
reaction was normalized by a second real-time PCR assay targeting the
GAPDH gene. The results presented are representative of three
independent experiments with similar results 6 standard deviation.
Asterisks indicate significant differences (*, P,0.05; **, P,0.01).
doi:10.1371/journal.pone.0086698.g003
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All together, our results obtained by measuring Ad5 attachment,
internalization and Ad5-mediated transgene expression strongly
suggest that RhoB plays a role in Ad5 transport from cell
membrane to the nucleus. We have put considerable effort into
characterizing trafficking of Ad5wt in HEp2 and CK2 cells after
RhoB silencing. Although in most experiments we have seen more
viruses located close to the nucleus after RhoB silencing, indicating
that RhoB can interfere with successful transport of Ad5 to the
nucleus, we have been unable to quantify these changes.
Characterization of the role of RhoB in transgene expression of
Ad5 will require in-depth study of the intracellular transport of
Ad5 after RhoB silencing, which is beyond the scope of the present
work.
Discussion
One of the standard cancer therapies is chemotherapy, for
which development of drug resistance to chemotherapy presents a
major challenge. In the last decade there have been several studies
reporting a beneficial effect from combined adenovirus-mediated
gene therapy and chemotherapy in cancer treatment
[23,24,25,41]. It has been shown that Ad5-mediated transgene
expression is increased in several drug-resistant cell lines selected
by exposure to antitumor drugs. For instance, it has been reported
that Ad5-mediated gene transfer is more efficient in drug-resistant
human bladder cancer cells, making them more sensitive to Ad5-
vectored p53 gene therapy than drug-sensitive cells [42]. A few
reports in the literature have addressed the molecular mechanisms
involved [27, 28, present work]. In our previous study we show
that in the cisplatin-resistant HEp2-derived cell clone CA3ST,
increased Ad5-mediated transgene expression is secondary to up-
regulated expression of CAR and avb3 integrin [27]. We have also
described a cell model in which the level of Ad5-mediated
transgene expression was uncoupled from Ad5 attachment/
internalization. In particular, in the HEp2-derived vincristine-
resistant cell line VK2, increased transgene expression after
transduction with Ad5wt is caused by increased activity of the
RSV promoter used to drive transgene expression. While the
amount of internalized Ad5 DNA was essentially the same in VK2
and parental HEp2 cell lines, Ad5-mediated transgene expression
driven by the RSV promoter was significantly increased in VK2
cells (approximately 5-fold) [28]. Here, in a new cell model
consisting of parental HEp2 and the cisplatin-resistant cell clone
CK2, we have identified RhoB expression as a cause of differential
Ad5wt-mediated transgene expression.
Compared with parental HEp2 cells, cisplatin-resistant CK2
cells showed increased Ad5wt-mediated transgene expression
accompanied by moderately increased Ad5wt attachment and
internalization. While the difference in Ad5wt-mediated transgene
expression was 5-fold, the difference in attachment (approximately
1.5-fold) and internalization (approximately 1.5- to 1.8-fold) was
much less pronounced, suggesting that these two events could not
Figure 4. Decreasing RhoB expression increases Ad5wt-mediated transgene expression. HEp2 and CK2 cells were transfected with
control or RhoB siRNA. Twenty-four hours after transfection cells were replated in 96-well plates for Ad5wt-mediated transgene expression
measurement and 6-well plates for Western blot. Forty-eight hours after siRNA transfection, the level of RhoB was analyzed by Western blot and cells
in 96-well plates were transduced for 1 hour at 37uC with two-fold serial dilutions of Ad5wt. Twenty-four hours after infection, cells were stained for b-
galactosidase expression. The transgene expression obtained with an MOI of 104 pp/cell is presented. (A) Forty-eight hours post-transfection the level
of RhoB protein was analyzed by Western blot, i.e. at the time of Ad5wt transduction whose results are presented in C and D. Actin was used as a
loading control. A representative blot of two independent experiments is presented. (B) Densitometric analysis of Western blot presented in (A). Data
are presented as relative to RhoB expression in HEp2 cells that was set as 100%. (C) Ad5wt-mediated transgene expression in HEp2 and CK2 cells
transfected with control or RhoB-specific siRNAs. (D). Data shown in (C) are presented as relative to control siRNA in HEp2 and CK2 cells, respectively.
The results presented in (C) and (D) are representative of three independent experiments with similar results 6 standard deviation.
doi:10.1371/journal.pone.0086698.g004
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entirely account for increased Ad5wt-mediated transgene expres-
sion in the CK2 cell line. We showed that cisplatin resistance in
CK2 cells was accompanied by change in expression of several cell
surface molecules involved in adenovirus infection. In CK2 cells,
as compared with parental HEp2 cells, we observed increased
expression of CAR, the integrin heterodimer a3b1 and integrin
subunits b1 and a5, as well as down-regulation of integrin
heterodimer avb5. We have tested the capacity of CAR up-
regulation to enhance Ad5wt-mediated transgene expression in
parental HEp2 cells by isolating a cell clone overexpressing CAR.
In this instance, a 30% increase in the level of CAR led to an
approximately 1.7 fold increase in Ad5wt transduction (data not
shown). Increased expression of a5 and b1 subunits in CK2
implies increased expression of a5b1 integrin, which could also
contribute to increased attachment and internalization. Therefore,
it is likely that increased attachment/internalization of Ad5wt in
CK2 cells was the consequence of increased binding to the high
affinity receptor CAR and low affinity receptor a5b1. As regards
the integrin avb5, it can be a limiting factor for transgene
expression in HEp2 cells, as we have shown that Ad5wt-mediated
transgene expression is diminished when integrin avb5 is down-
regulated [11]. It is thus unlikely that the diminution in avb5 in
the CK2 cell line is responsible for increased attachment/
internalization in the CK2 cell line. Finally, while the role of
a3b1 integrin in adenovirus infection has received little attention,
one report indicates that a3b1 integrin is able to interact with
penton base in vitro, with the RGD motif being only one of
multiple binding sites [6]. Since no change was observed in Ad5-
mediated transgene expression in HEp2 and CK2 cells upon
transfection with a3-specific siRNA (data not shown), we have
concluded that a3b1 integrin is not responsible for increased Ad5-
mediated transgene expression in CK2 cells. Additional evidence
that differential receptor usage is not responsible for increased
Ad5-mediated transgene expression in the CK2 cell line is
provided by experiments with capsid-modified Ad5-based vectors
Figure 5. Decreasing RhoB expression by siRNA transfection
does not change Ad5wt attachment or internalization. Forty-
eight hours after transfection with control or RhoB-specific siRNAs, cells
were incubated with Ad5wt at an MOI 1000 pp/cell for 40 minutes on
ice. To measure attachment, unbound virus was removed and cells
were scraped off and pelleted. To measure internalization, unbound
viruses were removed and cells were incubated at 37uC for 40 minutes,
trypsinized and pelleted. Total DNA (cellular plus viral) was extracted
from cells and used as a sample for quantification of viral DNA by real-
time PCR using a region within hexon as the target sequence. The cell-
derived DNA content per PCR reaction was normalized by a second real-
time PCR assay targeting the GAPDH gene. (A). Attachment of Ad5wt in
HEp2 and CK2 cells transfected with control or RhoB-specific siRNAs
presented as fold of HEp2. (B). Internalization of Ad5wt in HEp2 and CK2
cells transfected with control or RhoB-specific siRNAs presented as fold
of HEp2. The results presented are representative of three independent
experiments with similar results6 standard deviation. Asterisks indicate
significant differences (*, P,0.05; **, P,0.01).
doi:10.1371/journal.pone.0086698.g005
Figure 6. RhoB influences Ad5wt intracellular trafficking. Confocal microscopy of attachment and internalization of fluorescently labeled
Ad5wt at MOI 46104 pp/cell in HEp2 and CK2 cells. Cells were incubated with Alexa Fluor 488-labeled virions for 60 minutes on ice. Unbound virus
was removed and cells were either fixed to measure attachment or fed with fresh medium and incubated at 37uC for 30 minutes before fixation to
allow virus internalization. Overlay of virus (green), nucleus stained with DRAQ5 (blue) and phase-contrast is shown. Scale bar presents 20 mm.
doi:10.1371/journal.pone.0086698.g006
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(Ad5D639, Ad5RGD4C and Ad5D639RGD4C). Irrespective of
their modification, all vectors gave rise to a comparable increase in
Ad5-mediated transgene expression in cisplatin-resistant CK2
cells. The classical adenovirus infection pathway can be roughly
divided into five stages that include binding, entry, endosomal
escape, translocation, and nuclear import [43]. For optimal
adenovirus-mediated transgene expression, all of these steps must
be efficient. Since the difference in Ad5-mediated transgene
expression between CK2 and HEp2 cells was much higher than
the difference in attachment/internalization, we hypothesized that
increased Ad5-mediated transgene expression in CK2 cells might
have been due to changed intracellular trafficking.
Besides integrins, adenovirus entry requires assembly of
clathrin-coated pits and invaginations of the plasma membrane.
These processes are all regulated by lipid kinases, actin-modulating
small GTPases and the large GTPase dynamin [13,44]. Recently,
it has been shown that down-regulation of RhoB is one of the
determinants of cisplatin resistance in CK2 cells [31]. Since CK2
cells durably display morphological differences with HEp2 cells
[30], it is possible that they have undergone changes in the
cytoskeleton that influence adenovirus internalization. Rho
GTPases, members of the Ras superfamily, are small GTP/
GDP-binding proteins that are found in all eukaryotes and are
involved in regulation of the actin cytoskeleton. It has been shown
that Rho GTPases also play an important role in a number of
physiological processes, such as membrane trafficking, transcrip-
tional control, regulation of cell adhesion, and cell cycle
progression [14]. The best studied Rho GTPases are RhoA, Rac
and CdC42. Three highly homologous isoforms, RhoA, RhoB and
RhoC, induce stress fibers. Rac1 stimulates lamellipodium and
membrane ruffle formation, while Cdc42 participates in regulation
of cell polarity and formation of filopodia. While RhoA and RhoC
exert their role in the cytosol, RhoB was the first member of the
Rho family found to localize to intracellular membrane vesicles
[45], and more particularly, endosomes [46]. Through its
interaction with endosomes, RhoB delays EGF-induced EGF-R
degradation by inhibiting the transfer from late endosomes to
lysosomes [47], while oscillation of RhoB GTPase activity is
essential for appropriate sorting decisions, and for directing
CXCR2 chemokine receptor degradation and recycling – events
that are required for optimal chemotaxis [19]. Finally, RhoB has
been shown to regulate endosome transport by promoting actin
assembly on endosomal membranes [18].
Given the role of RhoB in endosome sorting, we thought that
the difference in Ad5wt-mediated transgene expression between
HEp2 and CK2 cell lines might be related to differential RhoB
expression. Indeed, after transfecting HEp2 and CK2 cells with
RhoB siRNA we observed significantly increased Ad5wt-mediated
transgene expression in both cell lines. Moreover, increased
Ad5wt-mediated transgene expression in HEp2 and CK2 cells was
not caused by increased attachment or internalization, indicating
that the difference in Ad5-mediated transgene expression between
HEp2 and CK2 might be caused by a change in intracellular
trafficking of viral particles. Our conclusion that RhoB is involved
in Ad5wt-mediated transgene expression was reinforced by the
similar results obtained in the MDA-MB-435S cell line.
It is generally accepted that after docking to the CAR receptor
Ad5 binds av integrins and enters the cell by clathrin-mediated
endocytosis. After being internalized in endosomal vesicles,
adenovirus particles must escape from the endosome. Once
situated in the cell cytoplasm, adenovirus encounters an
abundance of molecules that impair its free diffusion. Thus, the
adenovirus requires some form of active transport to reach the
nucleus. Microtubules are cytoskeletal structures responsible for
various kinds of movements in all eukaryotic cells. Adenoviruses
use microtubules to travel toward the nucleus where they
subsequently dock with the nuclear pore complex. After being
attached to the microtubules, adenovirus particles travel toward
the microtubule organizing center (MTOC), which is typically
located at a perinuclear position [48].
In order to gain insight into intracellular trafficking of Ad5wt in
HEp2 and CK2 cell lines, we followed the fate of fluorescently
labeled Ad5wt by confocal microscopy. Thirty minutes after
initiation of internalization in CK2 cells, adenoviruses were
observed to be situated in close proximity to the nucleus, in a
location characteristic of MTOC. By contrast, in HEp2 cells
adenoviruses were found scattered throughout the cytoplasm,
suggesting far less efficient nuclear transport. Our observation is in
accordance with a study performed by Fernandez-Borja and
colleagues [18] in which they have shown that the activated form
of endosomal RhoB promotes polymerization of an actin coat
around early endosomes and induces their association with
subcortical actin fibers, thereby preventing their transport to the
juxtanuclear area. Endosomes dispersed in this manner show
reduced motility. In the same study, the authors hypothesized that
inactivation of RhoB prevents further actin polymerization, and
that depolymerization of the actin coat allows endosomes to bind
to microtubules via the minus-end directed motor dynein for
transport toward the microtubule minus-end [18]. Additional
support comes from a recently published work from Lajoie-
Mazenc and colleagues [49], in which they establish a direct link
between RhoB and microtubules. They identified the light chain
of the microtubule-associated protein MAP1A (LC2) as a novel
binding partner of RhoB, postulating that interactions between
RhoB and MAP1A/LC2 facilitate endocytotic vesicle trafficking
and regulate the trafficking of signaling molecules.
To the best of our knowledge, this is the first study that shows an
important role for RhoB in Ad5-mediated transgene expression.
We show here that down-regulation of RhoB significantly
increased Ad5-mediated transgene expression in HEp2 and CK2
cells, without changing the amount of attached or internalized
Ad5wt in either cell line. We showed that down-regulation of
RhoB in HEp2 cells to a level similar to that in CK2 cells
increased Ad5-mediated transgene expression in HEp2 to the level
observed in CK2. We also observed different Ad5wt trafficking
pattern between HEp2 and CK2 cells. Based on our results we
conclude that increased Ad5-mediated transgene expression in
CK2 cells as compared with HEp2 cells is due also to altered
Ad5wt trafficking from membrane to nucleus. We hypothesize that
this is caused by diminished RhoB expression. The detailed
mechanisms underlying this phenomenon remain to be deter-
mined.
Our results may have important clinical implications in that
they provide further evidence suggesting that development of drug
resistance, while representing a major obstacle in standard cancer
treatment, may cause changes that can be rather beneficial for
alternative therapeutic approaches, such as gene therapy. Here we
show that decreased RhoB expression, which was identified as a
cause of cisplatin resistance in the CK2 cell line, is also responsible
for increased Ad5-mediated transgene expression that is unrelated
to increased entry of Ad5. This feature of drug-resistant cells might
be gainfully exploited in cancer gene therapy of drug-resistant
tumors with down-regulated RhoB expression. In particular,
enhanced Ad5-mediated transgene expression, secondary to
diminished expression of RhoB, may enable reduction in the
required dose of Ad5 in clinical applications.
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Supporting Information
Figure S1 Decreasing RhoB expression increases Ad5-
mediated transgene expression in human breast carci-
noma MDA-MB-435S cell line. Forty-eight hours after
transfection with siRNA, cells were plated in 96-well plates and,
24 hours later, transduced for 1 hour at 37uC with two-fold serial
dilutions of Ad5wt. Twenty-four hours after transduction, cells
were stained for b-galactosidase expression. The transgene
expression obtained with an MOI of 104 pp/cell is presented.
The data presented are representative of three independent
experiments with similar results 6 standard deviation.
(TIF)
Figure S2 Cell surface levels of CAR, integrin heterodi-
mers a3b1, integrin subunits a5 and b1 on HEp2 and
CK2 cells after transfection with control or RhoB
specific siRNA. Cells were detached by Versene and incubated
with murine monoclonal antibodies or isotype-matched antibody
as a negative control. After incubation with the secondary reagent
(PE-conjugated anti-mouse antibody), labeled cells were analyzed
by flow cytometry. Mean fluorescence intensities relative to
untransfected HEp2 cells obtained in three independent experi-
ments that gave similar results are shown.
(TIF)
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